XTLB

XTL Biopharmaceuticals Ltd.

HealthcareBiotechnologyILUSDPeers →Country macro →

$2.54

LiveJun 18, 2026

Market cap

$6.01M

52w range

2.01 – 10.28

P / E

—

EPS

—

Volume

10.67K

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on XTL Biopharmaceuticals Ltd.’s valuation

○

Sell-side estimates and price targets skew heavily to US large-caps. We don't have consensus data for this issuer yet.